Kateřina Mičová

Metabolite Profiling of the Plasma and Leukocytes of Chronic Myeloid Leukemia Patients

Jitka Široká, David Friedecký, Edgar Faber et al. · Journal of Proteome Research · 2016 · 49 citations

Mixed-phenotype Acute Leukemia, Immunology, Pathology +17

Flow injection analysis vs. ultra high performance liquid chromatography coupled with tandem mass spectrometry for determination of imatinib in human plasma

Kateřina Mičová, David Friedecký, Edgar Faber et al. · Clinica Chimica Acta · 2010 · 42 citations

Health Sciences, Analytical Instrumentation, Gas Chromatography +14

Lipidomic and metabolomic analysis reveals changes in biochemical pathways for non-small cell lung cancer tissues

Eva Cífková, Radana Brumarová, Magdaléna Ovčačíková et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2021 · 26 citations

Biochemistry, Medicine, Cancer Growth +11

A lower dosage of imatinib is sufficient to maintain undetectable disease in patients with chronic myeloid leukemia with long-term low-grade toxicity of the treatment

Edgar Faber, Martina Divoká, Ivana Skoumalová et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2015 · 25 citations

Dr Jekyll and Mr Hyde: a strange case of 5-ethynyl-2′-deoxyuridine and 5-ethynyl-2′-deoxycytidine

Anna Ligasová, Radek Liboska, David Friedecký et al. · Open Biology · 2016 · 25 citations · Full text

Chromatin, Medicinal Chemistry, Dr Jekyll +12